Jeremy Delinsky
CIK 1634427 · Chief Technology Officer · last filed 2024-11-19
Jeremy Delinsky is a Chief Technology Officer who has filed 22 SEC Form 4 insider transactions across 3 companies since 2015. The most recent filing shows the insider disposed of $385.7K of RCM on Nov 19, 2024. Across all open-market trades the lifetime net is −$1.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $5.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$5.60M
3
22
-$1.29M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| R1 RCM Inc. /DE (RCM) Delisted | Director | 0 | $14.31 | $0 | $0 | 3 | 2024-11-19 |
| W | Chief Technology Officer | 72,194 | $77.59 | $5.60M | -$872.1K | 15 | 2017-05-03 |
| ATHENAHEALTH INC (ATHN) Delisted | SVP, Chief Product Officer | 8,524 | $9.59 | $81.7K | -$420.1K | 4 | 2015-04-03 |
Recent Filings
22 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-11-19 | R1 RCM Inc. /DE (RCM) Delisted | Disp (D) | −26,975 | -$385.7K | EDGAR |
| 2024-05-23 | R1 RCM Inc. /DE (RCM) Delisted | Grant (A) | +15,651 | $0 | EDGAR |
| 2023-05-19 | R1 RCM Inc. /DE (RCM) Delisted | Grant (A) | +11,324 | $0 | EDGAR |
| 2017-05-03 | W | Mixed | +3,106 | -$123.8K | EDGAR |
| 2017-04-04 | W | Mixed | +3,885 | -$79.1K | EDGAR |
| 2017-03-16 | W | Mixed | +232 | -$4.3K | EDGAR |
| 2017-03-02 | W | Mixed | +3,906 | -$73.7K | EDGAR |
| 2017-02-01 | W | Mixed | +3,872 | -$80.9K | EDGAR |
| 2017-01-03 | W | Mixed | +3,763 | -$71.0K | EDGAR |
| 2016-12-16 | W | Mixed | +177 | -$6.4K | EDGAR |